Literature DB >> 33078207

The structure and phase of tau: from monomer to amyloid filament.

Yifan Zeng1,2, Jing Yang1,2, Bailing Zhang1,2, Meng Gao1,2, Zhengding Su1,2, Yongqi Huang3,4.   

Abstract

Tau is a microtubule-associated protein involved in regulation of assembly and spatial organization of microtubule in neurons. However, in pathological conditions, tau monomers assemble into amyloid filaments characterized by the cross-β structures in a number of neurodegenerative diseases known as tauopathies. In this review, we summarize recent progression on the characterization of structures of tau monomer and filament, as well as the dynamic liquid droplet assembly. Our aim is to reveal how post-translational modifications, amino acid mutations, and interacting molecules modulate the conformational ensemble of tau monomer, and how they accelerate or inhibit tau assembly into aggregates. Structure-based aggregation inhibitor design is also discussed in the context of dynamics and heterogeneity of tau structures.

Entities:  

Keywords:  Conformation transition; Drug design; Intrinsically disordered protein; Liquid–liquid phase separation; Protein aggregation

Year:  2020        PMID: 33078207     DOI: 10.1007/s00018-020-03681-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  163 in total

Review 1.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Authors:  Justin M Long; David M Holtzman
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

Review 2.  Tau Proteins and Tauopathies in Alzheimer's Disease.

Authors:  Fong Ping Chong; Khuen Yen Ng; Rhun Yian Koh; Soi Moi Chye
Journal:  Cell Mol Neurobiol       Date:  2018-01-03       Impact factor: 5.046

Review 3.  The many faces of tau.

Authors:  Meaghan Morris; Sumihiro Maeda; Keith Vossel; Lennart Mucke
Journal:  Neuron       Date:  2011-05-12       Impact factor: 17.173

Review 4.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 5.  Tau and tauopathies.

Authors:  Gloria Lee; Chad J Leugers
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

6.  Tau regulates the localization and function of End-binding proteins 1 and 3 in developing neuronal cells.

Authors:  Carmen Laura Sayas; Elena Tortosa; Flavia Bollati; Sacnicte Ramírez-Ríos; Isabelle Arnal; Jesús Avila
Journal:  J Neurochem       Date:  2015-04-08       Impact factor: 5.372

7.  Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure.

Authors:  John Berriman; Louise C Serpell; Keith A Oberg; Anthony L Fink; Michel Goedert; R Anthony Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

Review 8.  Tau and neurodegenerative disease: the story so far.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Nat Rev Neurol       Date:  2015-12-04       Impact factor: 42.937

Review 9.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders.

Authors:  Carlo Ballatore; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2007-09       Impact factor: 34.870

Review 10.  Tau-based therapies in neurodegeneration: opportunities and challenges.

Authors:  Chuanzhou Li; Jürgen Götz
Journal:  Nat Rev Drug Discov       Date:  2017-10-06       Impact factor: 84.694

View more
  7 in total

1.  HS3ST2 expression induces the cell autonomous aggregation of tau.

Authors:  M B Huynh; N Rebergue; H Merrick; W Gomez-Henao; E Jospin; D S F Biard; D Papy-Garcia
Journal:  Sci Rep       Date:  2022-06-27       Impact factor: 4.996

Review 2.  Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications.

Authors:  Niccolò Candelise; Silvia Scaricamazza; Illari Salvatori; Alberto Ferri; Cristiana Valle; Valeria Manganelli; Tina Garofalo; Maurizio Sorice; Roberta Misasi
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

Review 3.  The Role of Post-Translational Modifications on the Structure and Function of Tau Protein.

Authors:  Haiqiong Ye; Yue Han; Ping Li; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2022-03-24       Impact factor: 2.866

Review 4.  14-3-3 Proteins are Potential Regulators of Liquid-Liquid Phase Separation.

Authors:  Xianlong Huang; Zhiwen Zheng; Yixin Wu; Meng Gao; Zhengding Su; Yongqi Huang
Journal:  Cell Biochem Biophys       Date:  2022-02-10       Impact factor: 2.989

5.  Design, Synthesis, and Bioactivity of Novel Bifunctional Small Molecules for Alzheimer's disease.

Authors:  Meihao Liang; Lili Gu; Hongjie Zhang; Jingli Min; Zunyuan Wang; Zhen Ma; Chixiao Zhang; Shenxin Zeng; Youlu Pan; Dongmei Yan; Zhengrong Shen; Wenhai Huang
Journal:  ACS Omega       Date:  2022-07-20

6.  IDPConformerGenerator: A Flexible Software Suite for Sampling the Conformational Space of Disordered Protein States.

Authors:  João M C Teixeira; Zi Hao Liu; Ashley Namini; Jie Li; Robert M Vernon; Mickaël Krzeminski; Alaa A Shamandy; Oufan Zhang; Mojtaba Haghighatlari; Lei Yu; Teresa Head-Gordon; Julie D Forman-Kay
Journal:  J Phys Chem A       Date:  2022-08-28       Impact factor: 2.944

Review 7.  Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered Approach.

Authors:  Xavier Morató; Vanesa Pytel; Sara Jofresa; Agustín Ruiz; Mercè Boada
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.